Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

Retracted: A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells

(2008) Shoko Makishi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Aplidin, a Marine Organism-Derived Compound with Potent Antimyeloma Activity In vitro and In vivo

(2008) C. S. Mitsiades et al.   CANCER RESEARCH

The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib

(2008) J. S. Carew et al.   CANCER RESEARCH

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

(2008) Masako Seki et al.   CLINICAL IMMUNOLOGY

Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway

(2008) Chengrong Lu et al.   FEBS LETTERS

Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices

(2008) A. Nobumoto et al.   GLYCOBIOLOGY

Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin

(2008) Junya Kuroda et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY